Abstract:Gastric cancer (GC) is one of the most common malignancies which has high incidence and mortality worldwide. Peritoneal dissemination is the main route of metastasis in advanced GC. However, few reliable diagnostic or prognostic biomarkers are available for peritoneal metastasis of GC. This study aimed to investigate the effect of lipid phosphate phosphatase-related protein type 4 (LPPR4) on the prognosis of peritoneal metastasis in GC, so as to explore the underlying molecular mechanisms and clinical significance of the process. Differentially expressed genes (DEGs) between tumor tissues and adjacent normal tissues were identified. The prognostic values of the DEGs were tested in two independent cohorts (TCGA-STAD cohort and GSE62254 cohort). Eight DEGs including LPPR4 with prognostic value in GC peritoneal metastasis were identified. The expression of LPPR4 increased in peritoneal metastasis of GC tissues, and high LPPR4 expression was associated with poor overall survival in GC. Loss- and gain-of functional experiments were performed to reveal that LPPR4 could promote the migration, invasion and adhesion abilities of GC cells in vitro. Tumor peritoneal dissemination was investigated in a mouse model to reveal that LPPR4 could promote peritoneal metastasis of GC cells in vivo. According to the Kyoto Encyclopedia of Genes and Genomics (KEGG) and gene set enrichment analysis (GSEA), LPPR4 was found to be related to focal adhesion, cell adhesion molecules (CAMs) and ECM-receptor interaction pathways. LPPR4 knockdown significantly inhibited the expression of integrin α1, integrin α2, integrin α5, integrin α6, integrin α7, p-FAK, p-Akt, p-Src and MMP2. Moreover, this process was regulated by the Specificity Protein 1 (Sp1) transcription factor. Taken together, LPPR4 plays an essential role in promoting peritoneal metastasis of GC through Sp1/integrin α/FAK signaling, and acts as a novel biomarker of prognosis of GC peritoneal metastasis. The results suggest that LPPR4 may serve as a new therapeutic target for patients with GC peritoneal metastasis.

LHPP Suppresses Gastric Cancer Progression Via the PI3K/AKT/mTOR Signaling Pathway.

Phospholysine Phosphohistidine Inorganic Pyrophosphate Phosphatase Suppresses Insulin‐like Growth Factor 1 Receptor Expression to Inhibit Cell Adhesion and Proliferation in Gastric Cancer

Does the LHPP Gene Share a Common Biological Function in Pancancer Progression?

Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.

LHPP Suppresses Colorectal Cancer Cell Migration and Invasion in Vitro and in Vivo by Inhibiting Smad3 Phosphorylation in the TGF-β Pathway.

LHPP suppresses proliferation, migration, and invasion in hepatocellular carcinoma and pancreatic cancer by inhibiting EGFR signaling pathway

Tumor Suppressor LHPP Suppresses Cell Proliferation and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cell Lines.

m6A methylation mediates LHPP acetylation as a tumour aerobic glycolysis suppressor to improve the prognosis of gastric cancer

LHPP inhibits cell growth and migration and triggers autophagy in papillary thyroid cancer by regulating the AKT/AMPK/mTOR signaling pathway.

LHPP Inhibits the Proliferation and Metastasis of Renal Cell Carcinoma

As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma

Unlocking the potential of LHPP: Inhibiting glioma growth and cell cycle via the MDM2/p53 pathway

LHPP Suppresses Tumorigenesis of Intrahepatic Cholangiocarcinoma by Inhibiting the TGFβ/smad Signaling Pathway.

The Significance of LRPPRC Overexpression in Gastric Cancer

LGR6 Promotes the Progression of Gastric Cancer Through PI3K/AKT/mTOR Pathway.

LncRNA RP11-93B14.5 promotes gastric cancer cell growth through PI3K/AKT signaling pathway

Lower Expression of PH Domain Leucine-Rich Repeat Protein Phosphatase 1 (PHLPP1) Association with Poor Prognosis of Gastric Cancer.

LPPR4 Promotes Peritoneal Metastasis Via Sp1/integrin Α/fak Signaling in Gastric Cancer.

Role of Kruppel-like Factorï¿½4 in Regulating Inhibitor of Apoptosis-Stimulating Protein of P53 in the Progression of Gastric Cancer

EZH2-mediated Epigenetic Suppression of Lncrna PCAT18 Predicts a Poor Prognosis and Regulates the Expression of P16 by Interacting with Mir-570A-3p in Gastric Cancer

Downregulation of Long Noncoding RNA LINC01419 Inhibits Cell Migration, Invasion, and Tumor Growth and Promotes Autophagy Via Inactivation of the PI3K/Akt1/mTOR Pathway in Gastric Cancer.